Navamedic ASA: Renewed contract signed with Vitaflo International Limited PR Newswire OSLO, Norway, Dec. 21, 2023 OSLO, Norway, Dec. 21, 2023...
Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in Europe PR Newswire OSLO, Norway, Dec. 13, 2023 OSLO, Norway, Dec. 13...
Navamedic ASA: Record high quarter with above 50 percent growth PR Newswire OSLO, Norway, Nov. 1, 2023 OSLO, Norway, Nov. 1, 2023 /PRNewswire/...
Navamedic ASA: Invitation to 2023 3rd quarter presentation PR Newswire OSLO, Norway, Oct. 27, 2023 OSLO, Norway, Oct. 27, 2023 /PRNewswire/...
Navamedic ASA - Registration of share capital increase PR Newswire OSLO, Norway, Aug. 30, 2023 OSLO, Norway, Aug. 30, 2023 /PRNewswire/...
Navamedic ASA - Mandatory notification of trade by primary insider PR Newswire OSLO, Norway, Aug. 18, 2023 OSLO, Norway, Aug. 18, 2023...
NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee options PR Newswire OSLO, Norway, Aug. 18, 2023...
Navamedic ASA: Significant growth across the business PR Newswire OSLO, Norway, Aug. 11, 2023 OSLO, Norway, Aug. 11, 2023 /PRNewswire/...
Navamedic ASA: Invitation to 2023 2nd quarter presentation PR Newswire OSLO, Norway, Aug. 7, 2023 OSLO, Norway, Aug. 7, 2023 /PRNewswire/...
Navamedic ASA: Minutes of Annual General Meeting PR Newswire OSLO, Norway, June 1, 2023 OSLO, Norway, June 1, 2023 /PRNewswire/ -- The Annual...
Updated recommendation by the nomination committee of Navamedic ASA PR Newswire OSLO, Norway, May 31, 2023 OSLO, Norway, May 31, 2023...
Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer PR Newswire OSLO, Norway, May 26, 2023 OSLO...
Navamedic ASA: Notice of Annual General Meeting PR Newswire OSLO, Norway, May 11, 2023 OSLO, Norway, May 11, 2023 /PRNewswire/ -- The annual...
Navamedic ASA Q1 2023: Another strong quarter PR Newswire OSLO, Norway, May 11, 2023 OSLO, Norway, May 11, 2023 /PRNewswire/ -- Navamedic ASA...
Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads